Pfizer Will Pay $55 Million in Off-Label Case

[ad_1] Pfizer subsidiary Wyeth agreed to pay $55 million plus curiosity to settle allegations it promoted off-label use of its acid reflux disorder drug pantoprazole (Protonix), the corporate and authorities officers introduced. Wyeth promoted pantoprazole for indications past its label between February 2000 and June 2001, going as far as to govern persevering with medical … Read more